TY - JOUR
T1 - Assessment of the cardiovascular and gastrointestinal autonomic complications of diabetes
AU - Brock, Christina
AU - Brock, Birgitte
AU - Pedersen, Anne Grave
AU - Drewes, Asbjorn Mohr
AU - Jessen, Niels
AU - Farmer, Adam D.
PY - 2016/8/25
Y1 - 2016/8/25
N2 - The global prevalence of diabetes mellitus is increasing; arguably as a consequence of changes in diet, lifestyle and the trend towards urbanization. Unsurprisingly, the incidence of both micro and macrovascular complications of diabetes mirrors this increasing prevalence. Amongst the complications with the highest symptom burden, yet frequently under-diagnosed and sub-optimally treated, is diabetic autonomic neuropathy, itself potentially resulting in cardiovascular autonomic neuropathy and gastrointestinal (GI) tract dysmotility. The aims of this review are fourfold. Firstly to provide an overview of the pathophysiological processes that cause diabetic autonomic neuropathy. Secondly, to discuss both the established and emerging cardiometric methods for evaluating autonomic nervous system function in vivo. Thirdly, to examine the tools for assessing pan-GI and segmental motility and finally, we will provide the reader with a summary of putative non-invasive biomarkers that provide a pathophysiological link between low-grade neuro inflammation and diabetes, which may allow earlier diagnosis and intervention, which in future may improve patient outcomes.
AB - The global prevalence of diabetes mellitus is increasing; arguably as a consequence of changes in diet, lifestyle and the trend towards urbanization. Unsurprisingly, the incidence of both micro and macrovascular complications of diabetes mirrors this increasing prevalence. Amongst the complications with the highest symptom burden, yet frequently under-diagnosed and sub-optimally treated, is diabetic autonomic neuropathy, itself potentially resulting in cardiovascular autonomic neuropathy and gastrointestinal (GI) tract dysmotility. The aims of this review are fourfold. Firstly to provide an overview of the pathophysiological processes that cause diabetic autonomic neuropathy. Secondly, to discuss both the established and emerging cardiometric methods for evaluating autonomic nervous system function in vivo. Thirdly, to examine the tools for assessing pan-GI and segmental motility and finally, we will provide the reader with a summary of putative non-invasive biomarkers that provide a pathophysiological link between low-grade neuro inflammation and diabetes, which may allow earlier diagnosis and intervention, which in future may improve patient outcomes.
KW - Autonomic nervous system
KW - Gastrointestinal dysmotility
KW - Neuroinflammation
KW - Biomarkers
KW - Diabetic neuropathy
U2 - 10.4239/wjd.v7.i16.321
DO - 10.4239/wjd.v7.i16.321
M3 - Journal article
C2 - 27625746
SN - 1948-9358
VL - 7
SP - 321
EP - 332
JO - World Journal of Diabetes
JF - World Journal of Diabetes
IS - 16
ER -